Man Group’s Aptinyx Inc. Common Stock APTX Stock Holding History

Man Group’s Portfolio APTX Stock Details APTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-59,866	Closed	-$136K	–	2493
2022 Q1	$136K	Buy	+59,866	New	+$179K	﹤0.01%	2018

Other funds holding APTX

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Man Group's APTX Position: Q2 2022 in Review

Man Group sold out of Aptinyx Inc. Common Stock (APTX) in Q2 2022, closing a stake of 59,866 shares — an estimated $136K sold.

Man Group first reported a position in APTX in Q1 2022 and held it in 1 quarter. The position peaked at $136K in Q1 2022. 41 funds tracked by Wall St. Rank hold APTX as of Q2 2022.

Man Group reported no remaining Aptinyx Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Man Group sold 59,866 Aptinyx Inc. Common Stock shares in Q2 2022, an estimated $136K.
Man Group first reported a position in Aptinyx Inc. Common Stock in Q1 2022 and held it in 1 quarter.
Man Group's Aptinyx Inc. Common Stock position peaked at $136K in Q1 2022.
41 funds tracked by Wall St. Rank held Aptinyx Inc. Common Stock as of Q2 2022.

Based on Man Group's 13F filing for Q2 2022, filed 15 Aug 2022.